A Single-Site, Investigator Initiated Open-Label Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) an Adrenocorticotropic Hormone (ACTH) Analogue in Subjects with Moderately to Severely Active Psoriatic Arthritis (PsA)

Fiechtner Justus J, Montroy Tresa, June Joshua
2016 Journal of Dermatology Research and Therapy  
Although several therapeutic agents are available for psoriatic arthritis (PsA), each has limitations. Acthar ®
doi:10.23937/2469-5750/1510037 fatcat:ycxy7lp2vbbfrivcdovhlc76by